Skip to main content
. 2022 Mar 29;12:852515. doi: 10.3389/fonc.2022.852515

Figure 2.

Figure 2

BAP1 acts as a tumor suppressor in kidney renal clear cell carcinoma (KIRC). (A) Pan-cancer analysis of BAP1; (B) Immunohistochemical analysis of BAP1 in renal tumor and normal tissues; (C) Survival analysis comparing high- and low expression of BAP1; (D) Distribution of BAP1 genomic alterations inTCGA KIRC; (E, F) Relationship between copy number alterations and BAP1 expression: scatter plot (E), correlation plot (F). ns, not significant, p ≥ 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.